VOGLOYD M 0.2MG (Metformin (500mg) + Voglibose (0.2mg))

Vogloyd M 0.2 mg Tablet is classified as an anti-diabetic medication designed to assist in the management of type 2 diabetes in adults. This medication works by helping regulate blood glucose levels, which is crucial for individuals diagnosed with diabetes. It is important to take this tablet alongside food to enhance its effectiveness. Consistency is key; therefore, it is recommended to administer the medication at the same time each day as determined by your healthcare provider. The prescribing physician will establish the appropriate dosage, which may be adjusted over time based on your response as indicated by blood sugar measurements. Continuing treatment is critical, even if you feel well or see an improvement in your blood sugar management. Abruptly discontinuing the medication without professional guidance can lead to an increase in blood glucose levels, potentially resulting in serious complications such as kidney injury, vision loss, neuropathic issues, and limb loss. This medication should complement a comprehensive treatment plan that includes adhering to a nutritious diet, engaging in regular physical activity, and achieving weight loss as recommended by your healthcare professional, as lifestyle choices significantly influence diabetes control. Potential side effects include nausea, altered taste perception, decreased appetite, gas, abdominal discomfort, diarrhea, and skin rashes, which are typically transient and resolve independently. Should these effects persist or become bothersome, reach out to your healthcare provider, who can offer advice or alternative solutions. Vogloyd M 0.2 mg Tablet is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairments. Prior to initiating treatment, disclose any history of cardiovascular conditions to your healthcare provider. Regular monitoring of blood glucose levels is essential, along with possible assessments of blood cells and liver function.